\
&
Contact us
\
&
Contact us
Starts in 1 day from now
LocationOnline
ProgrammesWhile this session focuses on the Connecting Europe Facility (CEF)-Digital programme, it will also provide information on the future European Competitiveness Fund (ECF) and its funding opportunities for digital connectivity, and about the 2026 European Digital Connectivity (EDC) Awards competition.
More information on the event and the possibility to register can be found on the event website.
Background:
The European Commission proposal for the future European Competitiveness Fund (ECF) foresees as one of its pillars a "policy window Digital Leadership". According to plans, this new policy window will cover the thematic areas now covered by the Digital Europe programme and the CEF-Digital programme.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
